Page last updated: 2024-09-05

sb 216763 and Sarcopenia

sb 216763 has been researched along with Sarcopenia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahmad, F; Farber, J; Force, T; Freeman, TA; Gao, E; Lal, H; Ma, XL; Mangano, E; Shang, X; Vagnozzi, RJ; Wang, Y; Woodgett, J; Zhou, J	1

Other Studies

1 other study(ies) available for sb 216763 and Sarcopenia

Article	Year
GSK-3α is a central regulator of age-related pathologies in mice. The Journal of clinical investigation, 2013, Volume: 123, Issue:4 Topics: Aging; Animals; Autophagy; Bone and Bones; Cardiovascular Diseases; Cellular Senescence; Everolimus; Glycogen Synthase Kinase 3; Hepatocytes; Indoles; Kaplan-Meier Estimate; Knee Joint; Liver; Maleimides; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Muscle, Skeletal; Myocardium; Phenotype; Proteins; Sarcopenia; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases	2013

Article

Year

GSK-3α is a central regulator of age-related pathologies in mice.

The Journal of clinical investigation, 2013, Volume: 123, Issue:4

Topics: Aging; Animals; Autophagy; Bone and Bones; Cardiovascular Diseases; Cellular Senescence; Everolimus; Glycogen Synthase Kinase 3; Hepatocytes; Indoles; Kaplan-Meier Estimate; Knee Joint; Liver; Maleimides; Mechanistic Target of Rapamycin Complex 1; Mice; Mice, Knockout; Multiprotein Complexes; Muscle, Skeletal; Myocardium; Phenotype; Proteins; Sarcopenia; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases

2013